Wilson Sonsini Goodrich & Rosati advised Aramis Biosciences on the deal.Aramis Biosciences, a clinical-stage immuno-ophthalmology biopharmaceutical company, announced its launch and the completion of a $10.5…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now